Medicinal Chemistry
BioRelix and Dalton Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology
Published in Law and Health Weekly, December 1st, 2007
Dalton Medicinal Chemistry will utilize their proprietary insights to design and synthesize several novel classes of compounds against selected RiboSwitch targets. BioRelix will advance these compounds using their cutting edge battery of biological assays and thorough knowledge of RiboSwitch drug discovery and development.
Brian Dixon, BioRelix CEO commented: "We are pleased to have the opportunity to work with the creative team at Dalton Medicinal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Accounting and Economics
New accounting and economics findings from University of Minnesota described - Accounting and Economics
Studies from C. Leuz and co-researchers yield new data on accounting and economics - ADA Watch and the National Coalition for Disability Rights
Members of Congress and Disability Rights Advocates Support the Restoration of the Americans with Disabilities Act and Welcome Back the Road To Freedom Bus - Affymetrix, Inc.
Affymetrix Announces Pricing of Offering of Senior Convertible Notes Due 2038 - Affymetrix, Inc.
Affymetrix Announces Proposed $250 Million Offering of Senior Convertible Notes Due 2038 - Alcoholism
Youth and Community Groups Commend Rockstar for Taking 'The Buzz' out of its Energy Drinks - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
